Molecular cloning and functional expression of the pituitary adenylate cyclase-activating polypeptide type I receptor.
about
PACAP type I receptor activation regulates ECL cells and gastric acid secretionCloning and functional characterization of a third pituitary adenylate cyclase-activating polypeptide receptor subtype expressed in insulin-secreting cellsCalcitonin and calcitonin receptors: bone and beyondCalcitonin receptor gene expression in K562 chronic myelogenous leukemic cellsNeuropeptide regulation of signaling and behavior in the BNST.Primary cilium and sonic hedgehog signaling during neural tube patterning: role of GPCRs and second messengersN-terminal splice variants of the type I PACAP receptor: isolation, characterization and ligand binding/selectivity determinantsStructure of the human VIPR2 gene for vasoactive intestinal peptide receptor type 2Alpha-latrotoxin receptor, latrophilin, is a novel member of the secretin family of G protein-coupled receptorsMutations in the second cytoplasmic loop of the rat parathyroid hormone (PTH)/PTH-related protein receptor result in selective loss of PTH-stimulated phospholipase C activityMolecular cloning of a novel variant of the pituitary adenylate cyclase-activating polypeptide (PACAP) receptor that stimulates calcium influx by activation of L-type calcium channelsAgnathan VIP, PACAP and their receptors: ancestral origins of today's highly diversified formsThe pituitary adenylate cyclase-activating polypeptide is a physiological inhibitor of platelet activation.PACAP upsets stomach theory.Severe microcephaly induced by blockade of vasoactive intestinal peptide function in the primitive neuroepithelium of the mouseThe hop cassette of the PAC1 receptor confers coupling to Ca2+ elevation required for pituitary adenylate cyclase-activating polypeptide-evoked neurosecretion.PACAP is present in the olfactory system and evokes calcium transients in olfactory receptor neurons.Cloning and characterization of the signal transduction of four splice variants of the human pituitary adenylate cyclase activating polypeptide receptor. Evidence for dual coupling to adenylate cyclase and phospholipase C.Alternative splicing in the N-terminal extracellular domain of the pituitary adenylate cyclase-activating polypeptide (PACAP) receptor modulates receptor selectivity and relative potencies of PACAP-27 and PACAP-38 in phospholipase C activation.Macrophage Resistance to HIV-1 Infection Is Enhanced by the Neuropeptides VIP and PACAP.Peripheral PACAP inhibits gastric acid secretion through somatostatin release in micePAC1hop, null and hip receptors mediate differential signaling through cyclic AMP and calcium leading to splice variant-specific gene induction in neural cellsTargeting VIP and PACAP receptor signalling: new therapeutic strategies in multiple sclerosis.Regulation of neuroblast mitosis is determined by PACAP receptor isoform expressionA structure-function study of PACAP using conformationally restricted analogs: Identification of PAC1 receptor-selective PACAP agonistsCharacterisation of the mouse vasoactive intestinal peptide receptor type 2 gene, Vipr2, and identification of a polymorphic LINE-1-like sequence that confers altered promoter activity.STC1 induction by PACAP is mediated through cAMP and ERK1/2 but not PKA in cultured cortical neuronsCerebellar cortical-layer-specific control of neuronal migration by pituitary adenylate cyclase-activating polypeptide.Pituitary adenylate cyclase-activating polypeptide causes tyrosine phosphorylation of the epidermal growth factor receptor in lung cancer cells.Pharmacology and functions of receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide: IUPHAR review 1.PYK-2 is tyrosine phosphorylated after activation of pituitary adenylate cyclase activating polypeptide receptors in lung cancer cells.Neural tube expression of pituitary adenylate cyclase-activating peptide (PACAP) and receptor: potential role in patterning and neurogenesis.PACAP intraperitoneal treatment suppresses appetite and food intake via PAC1 receptor in mice by inhibiting ghrelin and increasing GLP-1 and leptinPituitary adenylate cyclase-activating polypeptide induces postsynaptically expressed potentiation in the intra-amygdala circuitC-terminal amidation of PACAP-38 and PACAP-27 is dispensable for biological activity at the PAC1 receptorVasoactive intestinal peptide-camptothecin conjugates inhibit the proliferation of breast cancer cells.Peptidergic activation of transcription and secretion in chromaffin cells. Cis and trans signaling determinants of pituitary adenylyl cyclase-activating polypeptide (PACAP).Functional characterization of structural alterations in the sequence of the vasodilatory peptide maxadilan yields a pituitary adenylate cyclase-activating peptide type 1 receptor-specific antagonist.G Protein-Coupled Receptor Endosomal Signaling and Regulation of Neuronal Excitability and Stress Responses: Signaling Options and Lessons From the PAC1 Receptor.Pituitary adenylate cyclase-activating polypeptide causes increased tyrosine phosphorylation of focal adhesion kinase and paxillin.
P2860
Q24562674-5744032B-4776-4611-B553-167A36EA875CQ24563905-562E1909-4B4F-4823-AFA6-B0141F34510AQ24643368-D4601DB3-A327-479B-AC19-D83B891FB107Q24797996-D51F45EC-4901-4F2B-8095-EEBE66492102Q26866326-849A1625-E566-4F04-8BE1-5A09DFB8383DQ27011207-7CBA9627-E655-42BB-8602-2ED300F1115DQ28139403-077606E6-3D9E-4A6B-AB33-62645B6ABD74Q28144174-F46AF567-33DE-445D-9D9F-29770F6549D3Q28570607-26C34871-C509-4BD0-A7A2-C66C19ED60B7Q28572877-960BC2C7-92EE-48CE-AABE-D4377C83204BQ28582265-A79E57DC-2E36-4C9F-8ACE-0D5849403258Q28728067-80A450EB-66B3-4B8A-91A7-FA6F80764A9FQ33360305-D326A8C4-CD2F-4F4C-AD09-45C1F77907A0Q33773959-BEE94B82-2BC9-4E19-9D49-E72EBBF01279Q34158279-2B35A5BC-59BF-4BAA-86EB-0FF8274DC07CQ34280490-BFE42A6D-C5DB-4D6B-B492-C111B6D5B4CEQ34291476-9A3F9344-FB37-4E51-B03E-93BD5F0532BAQ34384700-4D78196B-CA7A-4CB2-9FE2-416C217BA028Q34388733-A392F1BA-D8C4-4216-BCAF-24D53C36E515Q34789781-56D2CC1C-81B9-4F30-A023-867C31D28E45Q35047107-0176E813-2E16-4E0D-A05B-48E9B7D91896Q35184653-6FE7AAD2-E6CB-4BAC-B2C8-9CD6BBDCA7E1Q35295564-F75E4CD1-3A42-4F2E-9D3C-995309C0BAAAQ35309634-A8427FF3-9D16-4AD6-8F1F-B65D61848784Q35572290-0422165E-EDE9-420A-88C6-5AC0A0613775Q35648983-5E637F73-7C02-4729-AC17-0BB3C7A4E4A3Q35667237-E877B4A4-E0A9-44D4-AC53-FC624191D0DEQ35948321-90DA637C-D9A0-4CCE-841F-87B0940C4436Q35996716-3F2FB25F-2FE6-44AD-8463-5697E6F37D12Q36153216-384CBEED-4226-40BF-A65B-EF99D95A8F3EQ36166344-9C99EB30-F17A-4A01-B73A-1E2011AE0212Q36269174-7CFD471C-DE42-4451-9347-B9BE3D4D2339Q36297731-41BBBE43-CC1F-452B-860B-CE06830B96E2Q36374909-53EF78D3-3F07-4CAD-9E4B-C29C54022535Q36828479-6CB522B6-82CE-4CB6-9FEF-2563C70863FCQ37342513-62FDA205-91BB-441F-BF1D-F0165ED86C29Q37378273-A38BC922-7F24-4120-99A8-CDC3B0A52FC6Q38321988-814EDE72-79F6-4DB2-873E-1EC1D262FF17Q38962494-AD58B29F-6BD1-4A08-A9FA-9CF5506B649DQ39478560-F4B21DED-330F-4925-8FE9-0BA1323DC383
P2860
Molecular cloning and functional expression of the pituitary adenylate cyclase-activating polypeptide type I receptor.
description
1993 nî lūn-bûn
@nan
1993年の論文
@ja
1993年学术文章
@wuu
1993年学术文章
@zh-cn
1993年学术文章
@zh-hans
1993年学术文章
@zh-my
1993年学术文章
@zh-sg
1993年學術文章
@yue
1993年學術文章
@zh
1993年學術文章
@zh-hant
name
Molecular cloning and function ...... g polypeptide type I receptor.
@ast
Molecular cloning and function ...... g polypeptide type I receptor.
@en
type
label
Molecular cloning and function ...... g polypeptide type I receptor.
@ast
Molecular cloning and function ...... g polypeptide type I receptor.
@en
prefLabel
Molecular cloning and function ...... g polypeptide type I receptor.
@ast
Molecular cloning and function ...... g polypeptide type I receptor.
@en
P2860
P356
P1476
Molecular cloning and function ...... g polypeptide type I receptor.
@en
P2093
P2860
P304
P356
10.1073/PNAS.90.13.6345
P407
P577
1993-07-01T00:00:00Z